Mouse Mammary Tumor Virus c-rel Transgenic Mice Develop Mammary Tumors

REFERENCES

• Abbadie, C., N. Kabrun, F. Bouali, J. Smardova, D. Stehelin, B. Vandenbunder, and P. J. Enrietto. 1993. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 75: 899–912.
   PubMed Web of Science ®Google Scholar
• Alizadeh, A. A., M. B. Eisen, R. E. Davis, C. Ma, I. S. Lossos, A. Rosenwald, J. C. Boldrick, H. Sabet, T. Tran, X. Yu, J. I. Powell, L. Yang, G. E. Marti, T. Moore, J. Hudson, Jr., L. Lu, D. B. Lewis, R. Tibshirani, G. Sherlock, W. C. Chan, T. C. Greiner, D. D. Weisenburger, J. O. Armitage, R. Warnke, L. M. Staudt, and et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503–511.
   PubMed Web of Science ®Google Scholar
• Arsura, M., M. J. FitzGerald, N. Fausto, and G. E. Sonenshein. 1997. Nuclear factor-κB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ. 8: 1049–1059.
   PubMedGoogle Scholar
• Arsura, M., F. Mercurio, A. L. Oliver, S. S. Thorgeirsson, and G. E. Sonenshein. 2000. Role of the IκB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. Mol. Cell. Biol. 20: 5381–5391.
   PubMedGoogle Scholar
• Arsura, M., and G. E. Sonenshein. 2001. The roles of the c-myc and c-myb oncogenes in hematopoiesis and leukemogenesis, p. 521–549. In K. Ravid and J. Licht (ed.), Transcription factors: normal and malignant development of blood cells. Wiley-Liss Inc., New York, N.Y.
   Google Scholar
• Bargou, R. C., C. Leng, D. Krappmann, F. Emmerich, M. Y. Mapara, K. Bommert, H. D. Royer, C. Scheidereit, and B. Dorken. 1996. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 87: 4340–4347.
   PubMed Web of Science ®Google Scholar
• Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell 72: 729–739.
   PubMed Web of Science ®Google Scholar
• Brantley, D. M., C. L. Chen, R. S. Muraoka, P. B. Bushdid, J. L. Bradberry, F. Kittrell, D. Medina, L. M. Matrisian, L. D. Kerr, and F. E. Yull. 2001. Nuclear factor-κB (NF-κB) regulates proliferation and branching in mouse mammary epithelium. Mol. Biol. Cell 12: 1445–1455.
   PubMed Web of Science ®Google Scholar
• Calaf, G., and J. Russo. 1996. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14: 483–492.
   Google Scholar
• Cao, Y., G. Bonizzi, T. N. Seagroves, F. R. Greten, R. Johnson, E. V. Schmidt, and M. Karin. 2001. IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107: 763–775.
   PubMed Web of Science ®Google Scholar
• Cardiff, R. D., and R. J. Munn. 1995. Comparative pathology of mammary tumorigenesis in transgenic mice. Cancer Lett. 90: 13–19.
   PubMed Web of Science ®Google Scholar
• Catz, S. D., and J. L. Johnson. 2001. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 20: 7342–7351.
   PubMed Web of Science ®Google Scholar
• Chen, C., L. C. Edelstein, and C. Gelinas. 2000. The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-xL. Mol. Cell. Biol. 20: 2687–2695.
   PubMed Web of Science ®Google Scholar
• Clarkson, R. W., J. L. Heeley, R. Chapman, F. Aillet, R. T. Hay, A. Wyllie, and C. J. Watson. 2000. NF-κB inhibits apoptosis in murine mammary epithelia. J. Biol. Chem. 275: 12737–12742.
   PubMed Web of Science ®Google Scholar
• Cogswell, P. C., D. C. Guttridge, W. K. Funkhouser, and A. S. Baldwin, Jr. 2000. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 19: 1123–1131.
   PubMed Web of Science ®Google Scholar
• Dean, M., R. B. Kent, and G. E. Sonenshein. 1983. Transcriptional activation of immunoglobulin alpha heavy-chain genes by translocation of the c-myc oncogene. Nature 305: 443–446.
   PubMedGoogle Scholar
• Duyao, M. P., A. J. Buckler, and G. E. Sonenshein. 1990. Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. Proc. Natl. Acad. Sci. USA 87: 4727–4731.
   PubMed Web of Science ®Google Scholar
• Fantl, V., G. Stamp, A. Andrews, I. Rosewell, and C. Dickson. 1995. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9: 2364–2372.
   PubMed Web of Science ®Google Scholar
• Finco, T. S., J. K. Westwick, J. L. Norris, A. A. Beg, C. J. Der, and A. S. Baldwin, Jr. 1997. Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation. J. Biol. Chem. 272: 24113–24116.
   PubMed Web of Science ®Google Scholar
• Fujita, T., G. P. Nolan, H. C. Liou, M. L. Scott, and D. Baltimore. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev. 7: 1354–1363.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109: S81–96.
   PubMed Web of Science ®Google Scholar
• Gilmore, T. D. 1999. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogene 18: 6925–6937.
   PubMed Web of Science ®Google Scholar
• Gilmore, T. D., C. Cormier, J. Jean-Jacques, and M. E. Gapuzan. 2001. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Oncogene 20: 7098–7103.
   PubMedGoogle Scholar
• Grumont, R. J., A. Strasser, and S. Gerondakis. 2002. B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-κB regulated c-myc transcription. Mol. Cell 10: 1283–1294.
   PubMed Web of Science ®Google Scholar
• Guttridge, D. C., C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin, Jr. 1999. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19: 5785–5799.
   PubMed Web of Science ®Google Scholar
• Hinz, M., D. Krappmann, A. Eichten, A. Heder, C. Scheidereit, and M. Strauss. 1999. NF-κB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol. 19: 2690–2698.
   PubMed Web of Science ®Google Scholar
• Hrdlickova, R., J. Nehyba, and E. H. Humphries. 1994. In vivo evolution of c-rel oncogenic potential. J. Virol. 68: 2371–2382.
   PubMedGoogle Scholar
• Huang, D. B., Y. Q. Chen, M. Ruetsche, C. B. Phelps, and G. Ghosh. 2001. X-ray crystal structure of proto-oncogene product c-Rel bound to the CD28 response element of IL-2. Structure (Cambridge) 9: 669–678.
   PubMedGoogle Scholar
• Jager, R., U. Herzer, J. Schenkel, and H. Weiher. 1997. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene 15: 1787–1795.
   PubMed Web of Science ®Google Scholar
• Jeay, S., G. E. Sonenshein, M. C. Postel-Vinay, and E. Baixeras. 2000. Growth hormone prevents apoptosis through activation of nuclear factor-κB in interleukin-3-dependent Ba/F3 cell line. Mol. Endocrinol. 14: 650–661.
   PubMedGoogle Scholar
• Ji, L., M. Arcinas, and L. M. Boxer. 1994. NF-κ B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma. Mol. Cell. Biol. 14: 7967–7974.
   PubMedGoogle Scholar
• Joyce, D., C. Albanese, J. Steer, M. Fu, B. Bouzahzah, and R. G. Pestell. 2001. NF-κB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev. 12: 73–90.
   PubMed Web of Science ®Google Scholar
• Karin, M., Y. Cao, F. R. Greten, and Z. W. Li. 2002. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2: 301–310.
   PubMed Web of Science ®Google Scholar
• Kim, D. W., M. A. Sovak, G. Zanieski, G. Nonet, R. Romieu-Mourez, A. W. Lau, L. J. Hafer, P. Yaswen, M. Stampfer, A. E. Rogers, J. Russo, and G. E. Sonenshein. 2000. Activation of NF-κB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 21: 871–879.
   PubMed Web of Science ®Google Scholar
• Kindy, M. S., and G. E. Sonenshein. 1986. Regulation of oncogene expression in cultured aortic smooth muscle cells. Post-transcriptional control of c-myc mRNA. J. Biol. Chem. 261: 12865–12868.
   PubMed Web of Science ®Google Scholar
• Kontgen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9: 1965–1977.
   PubMed Web of Science ®Google Scholar
• Kurland, J. F., R. Kodym, M. D. Story, K. B. Spurgers, T. J. McDonnell, and R. E. Meyn. 2001. NF-κB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene. J. Biol. Chem. 276: 45380–45386.
   PubMedGoogle Scholar
• Landesman-Bollag, E., R. Romieu-Mourez, D. H. Song, G. E. Sonenshein, R. D. Cardiff, and D. C. Seldin. 2001. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 20: 3247–3257.
   PubMed Web of Science ®Google Scholar
• La Rosa, F. A., J. W. Pierce, and G. E. Sonenshein. 1994. Differential regulation of the c-myc oncogene promoter by the NF-κB rel family of transcription factors. Mol. Cell. Biol. 14: 1039–1044.
   PubMed Web of Science ®Google Scholar
• Lee, H., M. Arsura, M. Wu, M. Duyao, A. J. Buckler, and G. E. Sonenshein. 1995. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J. Exp. Med. 181: 1169–1177.
   PubMed Web of Science ®Google Scholar
• Liao, D. J., and R. B. Dickson. 2000. c-Myc in breast cancer. Endocr. Relat. Cancer 7: 143–164.
   PubMed Web of Science ®Google Scholar
• Mahler, J. F., W. Stokes, P. C. Mann, M. Takaoka, and R. R. Maronpot. 1996. Spontaneous lesions in aging FVB/N mice. Toxicol. Pathol. 24: 710–716.
   PubMed Web of Science ®Google Scholar
• Nakshatri, H., P. Bhat-Nakshatri, D. A. Martin, R. J. Goulet, Jr., and G. W. Sledge, Jr. 1997. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17: 3629–3639.
   PubMed Web of Science ®Google Scholar
• Pahl, H. L. 1999. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18: 6853–6866.
   PubMed Web of Science ®Google Scholar
• Pianetti, S., M. Arsura, R. Romieu-Mourez, R. J. Coffey, and G. E. Sonenshein. 2001. Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene 20: 1287–1299.
   PubMedGoogle Scholar
• Ravid, K., D. L. Beeler, M. S. Rabin, H. E. Ruley, and R. D. Rosenberg. 1991. Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter. Proc. Natl. Acad. Sci. USA 88: 1521–1525.
   PubMedGoogle Scholar
• Rayet, B., and C. Gelinas. 1999. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18: 6938–6947.
   PubMed Web of Science ®Google Scholar
• Rice, N. R., and M. K. Ernst. 1993. In vivo control of NF-kappa B activation by I kappa B alpha. EMBO J. 12: 4685–4695.
   PubMedGoogle Scholar
• Romieu-Mourez, R., E. Landesman-Bollag, D. C. Seldin, and G. E. Sonenshein. 2002. Protein kinase CK2 promotes aberrant activation of NF-κB, transformed phenotype and survival of breast cancer cells. Cancer Res. 62: 6770–6778.
   PubMed Web of Science ®Google Scholar
• Romieu-Mourez, R., E. Landesman-Bollag, D. C. Seldin, A. M. Traish, F. Mercurio, and G. E. Sonenshein. 2001. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-κB in breast cancer. Cancer Res. 61: 3810–3818.
   PubMedGoogle Scholar
• Rosner, A., K. Miyoshi, E. Landesman-Bollag, X. Xu, D. C. Seldin, A. R. Moser, C. L. MacLeod, G. Shyamala, A. E. Gillgrass, and R. D. Cardiff. 2002. Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am. J. Pathol. 161: 1087–1097.
   PubMed Web of Science ®Google Scholar
• Schneider, T. J., D. Grillot, L. C. Foote, G. E. Nunez, and T. L. Rothstein. 1997. Bcl-x protects primary B cells against Fas-mediated apoptosis. J. Immunol. 159: 4834–4839.
   PubMed Web of Science ®Google Scholar
• Schoenenberger, C. A., A. C. Andres, B. Groner, M. van der Valk, M. LeMeur, and P. Gerlinger. 1988. Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription. EMBO J. 7: 169–175.
   PubMed Web of Science ®Google Scholar
• Sicinski, P., J. L. Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621–630.
   PubMed Web of Science ®Google Scholar
• Sinn, E., W. Muller, P. Pattengale, I. Tepler, R. Wallace, and P. Leder. 1987. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49: 465–475.
   PubMed Web of Science ®Google Scholar
• Sonenshein, G. E. 1997. Rel/NF-kappa B transcription factors and the control of apoptosis. Semin. Cancer Biol. 8: 113–119.
   PubMed Web of Science ®Google Scholar
• Song, D. H., D. J. Sussman, and D. C. Seldin. 2000. Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells. J. Biol. Chem. 275: 23790–23797.
   PubMed Web of Science ®Google Scholar
• Sovak, M. A., M. Arsura, G. Zanieski, K. T. Kavanagh, and G. E. Sonenshein. 1999. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-κB/Rel expression. Cell Growth Differ. 10: 537–544.
   PubMedGoogle Scholar
• Sovak, M. A., R. E. Bellas, D. W. Kim, G. J. Zanieski, A. E. Rogers, A. M. Traish, and G. E. Sonenshein. 1997. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Investig. 100: 2952–2960.
   PubMed Web of Science ®Google Scholar
• Stanton, L. W., R. Watt, and K. B. Marcu. 1983. Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas. Nature 303: 401–406.
   PubMed Web of Science ®Google Scholar
• Stewart, T. A., P. K. Pattengale, and P. Leder. 1984. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38: 627–637.
   PubMed Web of Science ®Google Scholar
• Sumitomo, M., M. Tachibana, J. Nakashima, M. Murai, A. Miyajima, F. Kimura, M. Hayakawa, and H. Nakamura. 1999. An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells. J. Urol. 161: 674–679.
   PubMedGoogle Scholar
• Thiery, J. P. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2: 442–454.
   PubMed Web of Science ®Google Scholar
• Wang, T. C., R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669–671.
   PubMed Web of Science ®Google Scholar
• Westerheide, S. D., M. W. Mayo, V. Anest, J. L. Hanson, and A. S. Baldwin, Jr. 2001. The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G1 transition. Mol. Cell. Biol. 21: 8428–8436.
   PubMed Web of Science ®Google Scholar
• Wu, M., H. Lee, R. E. Bellas, S. L. Schauer, M. Arsura, D. Katz, M. J. FitzGerald, T. L. Rothstein, D. H. Sherr, and G. E. Sonenshein. 1996. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15: 4682–4690.
   PubMed Web of Science ®Google Scholar
• Yang, Y. A., O. Dukhanina, B. Tang, M. Mamura, J. J. Letterio, J. MacGregor, S. C. Patel, S. Khozin, Z. Y. Liu, J. Green, M. R. Anver, G. Merlino, and L. M. Wakefield. 2002. Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects. J. Clin. Investig. 109: 1607–1615.
   PubMed Web of Science ®Google Scholar
• Yu, Q., Y. Geng, and P. Sicinski. 2001. Specific protection against breast cancers by cyclin D1 ablation. Nature 411: 1017–1021.
   PubMed Web of Science ®Google Scholar
• Zhou, B. P., M. C. Hu, S. A. Miller, Z. Yu, W. Xia, S. Y. Lin, and M. C. Hung. 2000. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-κB pathway. J. Biol. Chem. 275: 8027–8031.
   PubMedGoogle Scholar
• Zong, W. X., L. C. Edelstein, C. Chen, J. Bash, and C. Gelinas. 1999. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev. 13: 382–387.
   PubMed Web of Science ®Google Scholar